We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Role of Registries in Medicare Coverage of New Alzheimer Disease Drugs.
- Authors
Odouard, Ilina C.; Socal, Mariana P.; Anderson, Gerard F.
- Abstract
This Viewpoint discusses how the design of the Centers for Medicare & Medicaid Services (CMS) registry could impact Medicare's ability to evaluate whether monoclonal antibodies are reasonable and necessary for patients with Alzheimer disease and help physicians understand when the drug is most beneficial.
- Subjects
ALZHEIMER'S disease; MEDICARE; MONOCLONAL antibodies; DRUGS; MEDICAID
- Publication
JAMA: Journal of the American Medical Association, 2023, Vol 330, Issue 14, p1331
- ISSN
0098-7484
- Publication type
Article
- DOI
10.1001/jama.2023.17131